New study to test third COVID-19 vaccine for people with weakened immune systems
Participants will be given either Pfizer, Moderna or Novavax as a third dose of vaccine The government-funded study follows the results of the OCTAVE trial showing that 89% of people who are immunocompromised or immunosuppressed generate antibodies… read more